ES2129342A1 - "formulacion de vacunas liposomales y su preparacion". - Google Patents

"formulacion de vacunas liposomales y su preparacion".

Info

Publication number
ES2129342A1
ES2129342A1 ES09602695A ES9602695A ES2129342A1 ES 2129342 A1 ES2129342 A1 ES 2129342A1 ES 09602695 A ES09602695 A ES 09602695A ES 9602695 A ES9602695 A ES 9602695A ES 2129342 A1 ES2129342 A1 ES 2129342A1
Authority
ES
Spain
Prior art keywords
preparation
antigens
phospholipids
formulation
vaccine formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09602695A
Other languages
English (en)
Other versions
ES2129342B1 (es
Inventor
Xamani Manuel Sabes
Roura Pilar Rubert
I Coromina Josep Ferres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Hipra SA
Original Assignee
Laboratorios Hipra SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Hipra SA filed Critical Laboratorios Hipra SA
Priority to ES9602695A priority Critical patent/ES2129342B1/es
Publication of ES2129342A1 publication Critical patent/ES2129342A1/es
Application granted granted Critical
Publication of ES2129342B1 publication Critical patent/ES2129342B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Formulación de vacunas liposomales y su preparación. La formulación se refiere a liposomas que contienen antígenos encapsulados en su interior, o bien, asociados a la membrana, con una concentración de fosfolípidos de 25 mg/g respecto al producto final. Los antígenos utilizados pueden ser víricos o fracciones antigénicas de origen bacteriano, como endotoxinas, factores de adhesión, etc. Los fosfolípidos utilizados son mayoritariamente lecitinas. A los fosfolípidos se les puede adicionar, en ocasiones, colesterol y también un antioxidante liposoluble. El procedimiento de preparación consiste en adicionar los fosfolípidos a una suspensión de los antígenos, homogeneizando la mezcla por recirculación por un microfluidificador. La formulación se usa para la preparación de vacunas liposomales de uso veterinario.
ES9602695A 1996-12-19 1996-12-19 "formulacion de vacunas liposomales y su preparacion". Expired - Lifetime ES2129342B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9602695A ES2129342B1 (es) 1996-12-19 1996-12-19 "formulacion de vacunas liposomales y su preparacion".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9602695A ES2129342B1 (es) 1996-12-19 1996-12-19 "formulacion de vacunas liposomales y su preparacion".

Publications (2)

Publication Number Publication Date
ES2129342A1 true ES2129342A1 (es) 1999-06-01
ES2129342B1 ES2129342B1 (es) 2000-03-16

Family

ID=8297082

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9602695A Expired - Lifetime ES2129342B1 (es) 1996-12-19 1996-12-19 "formulacion de vacunas liposomales y su preparacion".

Country Status (1)

Country Link
ES (1) ES2129342B1 (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004072A1 (en) * 1991-08-14 1993-03-04 The Associated Octel Company Limited METAL β-DIKETONATES
ES2070774A1 (es) * 1993-09-16 1995-06-01 Hipra Lab Sa Preparaciones liposomicas de farmacos o antigenos vacunales para medicina veterinaria.
EP0677295A1 (en) * 1993-10-29 1995-10-18 Tonen Corporation Liposome having oligosaccharide on the surface

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004072A1 (en) * 1991-08-14 1993-03-04 The Associated Octel Company Limited METAL β-DIKETONATES
ES2070774A1 (es) * 1993-09-16 1995-06-01 Hipra Lab Sa Preparaciones liposomicas de farmacos o antigenos vacunales para medicina veterinaria.
EP0677295A1 (en) * 1993-10-29 1995-10-18 Tonen Corporation Liposome having oligosaccharide on the surface

Also Published As

Publication number Publication date
ES2129342B1 (es) 2000-03-16

Similar Documents

Publication Publication Date Title
Alving Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens
AU631377B2 (en) Affinity associated vaccine
US5919480A (en) Liposomal influenza vaccine composition and method
US5658898A (en) Intravenous solutions for a derivative of staurosporine
CA2086831C (en) Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US5026557A (en) Adjuvant composition
ATE71303T1 (de) Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
CA2227761A1 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
JPH0665650B2 (ja) インタ−リユ−キン療法に関する改良
DE69115514T2 (de) Liposomenhaltige intranasale Impfstofformulierung
US4148876A (en) Biological preparations
AU668934B2 (en) Liposome composition
US20080131446A1 (en) Vaccine Composition
KR950700083A (ko) 경구용 백신(oral vaccine)
EP0356340B1 (en) Affinity associated vaccine
EP2027865A1 (en) Liposome having lipid membrane containing bacterial cell component
NZ502840A (en) High pressure homogenisation method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
GB1564500A (en) Biological preparations
ES2129342A1 (es) "formulacion de vacunas liposomales y su preparacion".
JPH05339169A (ja) 経口ワクチン
ES2093701T3 (es) Procedimiento para la preparacion de suspensiones acuosas de liposomas que contienen sustancias activas.
CA1225592A (en) Refined detoxified endotoxin
Jeannin et al. Liposome induction or enhancement of macrophage‐mediated cancer cell lysis
DE69505236T2 (de) Liposomen und deren verwendung insbesondere zur herstellung immunomodulatorischer mittel

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990601

Kind code of ref document: A1

Effective date: 19990601